Works matching IS 03618609 AND DT 2025 AND VI 100 AND IP 3
Results: 29
Association Between Anticoagulant‐Related Bleeding and Mortality in Patients With Solid Tumors and Cancer‐Associated Venous Thromboembolism.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 535, doi. 10.1002/ajh.27588
- By:
- Publication type:
- Article
Evaluating Minimal Residual Disease Negativity as a Surrogate Endpoint for Treatment Efficacy in Multiple Myeloma: A Meta‐Analysis of Randomized Controlled Trials.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 427, doi. 10.1002/ajh.27582
- By:
- Publication type:
- Article
Budesonide, Added to PTCy‐Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 383, doi. 10.1002/ajh.27581
- By:
- Publication type:
- Article
Primary Effusion Lymphoma Prognostic Score (PEL‐PS): A Validated International Prognostic Score in HIV‐Associated Primary Effusion Lymphoma.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 393, doi. 10.1002/ajh.27580
- By:
- Publication type:
- Article
Impact of Baseline Thrombocytopenia on Early Outcomes in Patients With Acute Venous Thromboembolism.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 375, doi. 10.1002/ajh.27579
- By:
- Publication type:
- Article
Limited Benefit of Routine Clinical Follow‐Up for Relapse Detection in Diffuse Large B‐Cell Lymphoma Patients in Complete Remission Following First‐Line Treatment.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 408, doi. 10.1002/ajh.27577
- By:
- Publication type:
- Article
Hyper‐CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome‐Negative B‐Cell Acute Lymphoblastic Leukemia.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 402, doi. 10.1002/ajh.27576
- By:
- Publication type:
- Article
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 417, doi. 10.1002/ajh.27575
- By:
- Publication type:
- Article
Clinical Characteristics and Prognosis of Pediatric Idiopathic Multicentric Castleman Disease.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 539, doi. 10.1002/ajh.27574
- By:
- Publication type:
- Article
CM313 Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma or Marginal Zone Lymphoma: A Multicenter, Phase 1 Dose‐Escalation and Dose‐Expansion Trial.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 531, doi. 10.1002/ajh.27573
- By:
- Publication type:
- Article
Unlocking Sanctuary Sites: The Efficacy of Brexucabtagene Autoleucel in Ocular B‐ALL Relapse.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 483, doi. 10.1002/ajh.27572
- By:
- Publication type:
- Article
Outcome of Splenectomy in JAK2 Inhibitor Treated Patients With Myelofibrosis: A Mayo Clinic Experience in 34 Consecutive Cases.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 527, doi. 10.1002/ajh.27570
- By:
- Publication type:
- Article
Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti‐CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 523, doi. 10.1002/ajh.27569
- By:
- Publication type:
- Article
Efficacy and Long‐Term Outcomes of Eltrombopag Treatment Within 6 Months of Diagnosis in Patients With Steroid Unresponsive or Dependent Immune Thrombocytopenia.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 516, doi. 10.1002/ajh.27568
- By:
- Publication type:
- Article
Effect of Ferric Derisomaltose on Fatigue in Iron Deficiency Anemia Associated With Abnormal Uterine Bleeding.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 497, doi. 10.1002/ajh.27555
- By:
- Publication type:
- Article
Risk Factors and Prognostic Markers for Posterior Reversible Encephalopathy Syndrome in Patients With Thalassemia Major After Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 520, doi. 10.1002/ajh.27566
- By:
- Publication type:
- Article
Treatment Effectiveness of Venetoclax‐Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real‐World Study.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 511, doi. 10.1002/ajh.27563
- By:
- Publication type:
- Article
Clinical Use of Eltrombopag and Avatrombopag in Pediatric ITP in China: A Real‐World Multicenter Retrospective Cohort Study.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 493, doi. 10.1002/ajh.27554
- By:
- Publication type:
- Article
The Importance of Controlling Terminal Complement Activity and Intravascular Hemolysis in Paroxysmal Nocturnal Hemoglobinuria (PNH).
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 505, doi. 10.1002/ajh.27556
- By:
- Publication type:
- Article
Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 507, doi. 10.1002/ajh.27553
- By:
- Publication type:
- Article
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA‐EPIFLUEHA Report.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 358, doi. 10.1002/ajh.27565
- By:
- Publication type:
- Article
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 439, doi. 10.1002/ajh.27539
- By:
- Publication type:
- Article
Evaluating the Role of Red Blood Cell Lifespan in Transfusion‐Dependent β‐Thalassemia and Impact of Thalidomide Treatment.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 501, doi. 10.1002/ajh.27557
- By:
- Publication type:
- Article
Correction to "Benefit of Axicabtagene Ciloleucel Versus Chemoimmunotherapy in Older Patients and/or Patients With Poor ECOG Performance Status With Relapsed or Refractory Large B‐Cell Lymphoma After 2 or More Lines of Prior Therapy".
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 542, doi. 10.1002/ajh.27551
- Publication type:
- Article
Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 450, doi. 10.1002/ajh.27546
- By:
- Publication type:
- Article
The Interplay Between Ophthalmic and Systemic Outcomes in Patients With Sickle Cell Disease and Concurrent Retinopathy—A Population‐Based Study.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 490, doi. 10.1002/ajh.27552
- By:
- Publication type:
- Article
Fulminant intravascular hemolysis resulting from Clostridium perfringens infection.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 481, doi. 10.1002/ajh.27511
- By:
- Publication type:
- Article
Peripheral blood smear reveals human granulocytic anaplasmosis, a rare cause of hemophagocytic lymphohistiocytosis.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 488, doi. 10.1002/ajh.27485
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2025, v. 100, n. 3, p. 355, doi. 10.1002/ajh.27390
- Publication type:
- Article